Stocktoria
REPLIGEN CORP RGEN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1986-04-29
REPLIGEN CORP insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Garland Jason K | CFO | 2026-06-25 | Sell | 733 | $145.00 |
| Madaus Martin D | director | 2026-05-14 | Grant | 995 | — |
| Konstantinov Konstantin | director | 2026-05-14 | Grant | 995 | — |
| EGLINTON MANNER CARRIE | director | 2026-05-14 | Grant | 995 | — |
| Mhatre Rohin | director | 2026-05-14 | Grant | 995 | — |
| Pax Margaret | director | 2026-05-14 | Grant | 995 | — |
| MUIR GLENN P | director | 2026-05-14 | Grant | 995 | — |
| DAWES KAREN A | director | 2026-05-14 | Grant | 995 | — |
Source: SEC EDGAR filings · CIK 0000730272 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.